Innovative procedure for prostate tissue treatment launched on the East Coast.
- First commercial Vanquish procedure performed on the East Coast
- Procedure offers a new option for prostate tissue ablation
- Francis Medical leads the way in urological treatments
Francis Medical has achieved a significant milestone by completing the first commercial Vanquish procedure on the East Coast, which focuses on prostate tissue ablation. The Vanquish procedure marks an innovative advancement in treating prostate conditions, aiming to provide patients with a less invasive option. This development is particularly notable for patients seeking alternatives in urological care.
The procedure applies radiofrequency energy to effectively ablate prostate tissue. This approach is designed to reduce complications associated with traditional surgical methods, offering patients a promising option for managing their prostate health. Francis Medical emphasizes the importance of continued advancements in prostate treatments and aims to expand access to this innovative procedure across the region.
The successful execution of this first Vanquish procedure signifies a step forward in minimally invasive urological treatments. Francis Medical continues to focus on enhancing healthcare solutions for prostate conditions while promoting advancements in medical technology.
